This report aims to provide a comprehensive presentation of the global market for Oncology, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology.

The Oncology market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oncology market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Oncology market size in 2022 is 305070.00 million US dollars, and it is expected to be 516096.40 million US dollars by 2029, with a compound annual growth rate of 7.80% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Oncology market include Aegerion Pharmaceuticals Inc., Abbvie Inc., Ability Pharma, Acadia Pharmaceuticals Inc., and Amgen Inc.. The share of the top 3 players in the Oncology market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, in which North America accounted for XX%, Europe accounted for XX% of Oncology market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Cancer Diagnostics accounted for XX% of Oncology market in 2022. Cancer Treatment share of XX%.
Hospitals accounted for XX% of the Oncology market in 2022. Diagnostic Laboratories accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapters 2-7: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Oncology market type, application, player and country market segmentation data.
Chapters 8-9: Segmented the global Oncology market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 10: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Oncology industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapter 12: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
South America
Brazil
Argentina
Colombia
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Aegerion Pharmaceuticals Inc.
Abbvie Inc.
Ability Pharma
Acadia Pharmaceuticals Inc.
Amgen Inc.
Takeda Oncology
Aslan Pharmaceuticals Ltd.
Aspen Pharmacare Holdings Limited.
Astrazeneca
Athenex Inc.

Types list
Cancer Diagnostics
Cancer Treatment

Application list
Hospitals
Diagnostic Laboratories
Diagnostic Imaging Centers
Academia

Table of Content

1 Oncology Market Introduction and Overview
1.1 Oncology Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Global Market Growth Trends Analysis
2.1 Global Oncology Market Size & Forecast (2018-2029)
2.2 Oncology Growth Trends Analysis by Regions
2.2.1 Oncology Market Size by Regions: 2018 VS 2023 VS 2029
2.2.2 Oncology Historic Market Size by Regions (2018-2023)
2.2.3 Oncology Forecasted Market Size by Regions (2023-2029)
2.2.4 North America Oncology Market Size & Forecast (2018-2029)
2.2.5 Europe Oncology Market Size & Forecast (2018-2029)
2.2.6 Asia-Pacific Oncology Market Size & Forecast (2018-2029)
2.2.7 Latin America Oncology Market Size & Forecast (2018-2029)
2.2.8 Middle East & Africa Oncology Market Size & Forecast (2018-2029)
3 North America
3.1 North America Oncology Revenue by Countries
3.1.1 North America Oncology Revenue by Countries (2018-2029)
3.2 North America Oncology Revenue by Players
3.3 North America Oncology Revenue by Types
3.4 North America Oncology Revenue by Applications
3.5 United States
3.6 Canada
4 Asia Pacific
4.1 Asia Pacific Oncology Revenue by Countries
4.1.1 Asia Pacific Oncology Revenue by Countries (2018-2029)
4.2 Asia Pacific Oncology Revenue by Players
4.3 Asia Pacific Oncology Revenue by Types
4.4 Asia Pacific Oncology Revenue by Applications
4.5 China
4.6 Japan
4.7 Korea
4.8 Southeast Asia
4.9 India
4.10 Australia
5 Europe
5.1 Europe Oncology Revenue by Countries
5.1.1 Europe Oncology Revenue by Countries (2018-2029)
5.2 Europe Oncology Revenue by Players
5.3 Europe Oncology Revenue by Types
5.4 Europe Oncology Revenue by Applications
5.5 Germany
5.6 France
5.7 UK
5.8 Italy
5.9 Russia
5.10 Spain
5.11 Nordic
6 Latin America
6.1 Latin America Oncology Revenue by Countries
6.1.1 Latin America Oncology Revenue by Countries (2018-2029)
6.2 Latin America Oncology Revenue by Players
6.3 Latin America Oncology Revenue by Types
6.4 Latin America Oncology Revenue by Applications
6.5 Brazil
6.6 Argentina
6.7 Colombia
6.8 Mexico
7 Middle East & Africa
7.1 Middle East & Africa Oncology Revenue by Countries
7.1.1 Middle East & Africa Oncology Revenue by Countries (2018-2029)
7.2 Middle East & Africa Oncology Revenue by Players
7.3 Middle East & Africa Oncology Revenue by Types
7.4 Middle East & Africa Oncology Revenue by Applications
7.5 Egypt
7.6 South Africa
7.7 Israel
7.8 Turkey
7.9 GCC Countries
8 Global Oncology Historical and Forecast Market Analysis by Type
8.1 Global Oncology Revenue and Market Share by Type
8.2 Global Oncology Market Forecast by Type (2023-2029)
9 Global Oncology Historical and Forecast Market Analysis by Application
9.1 Global Oncology Revenue Market Share by Application (2018-2023)
9.2 Oncology Market Forecast by Application (2023-2029)
10 Oncology Industry Dynamic Analysis
10.1 Oncology Market Trends Analysis
10.2 Oncology Market Drivers Analysis
10.3 Oncology Market Challenges Analysis
10.4 Oncology Market Restraints Analysis
10.5 Oncology Industry Mergers & Acquisitions
10.6 Oncology Industry New Entrants and Expansion Plans
11 Players Profiles
11.1 Aegerion Pharmaceuticals Inc.
11.1.1 Aegerion Pharmaceuticals Inc. Company Profile
11.1.2 Oncology Product Overview
11.1.3 Aegerion Pharmaceuticals Inc. Oncology Market Performance (2018-2023)
11.1.4 Aegerion Pharmaceuticals Inc. Business Overview
11.2 Abbvie Inc.
11.2.1 Abbvie Inc. Company Profile
11.2.2 Oncology Product Overview
11.2.3 Abbvie Inc. Oncology Market Performance (2018-2023)
11.2.4 Abbvie Inc. Business Overview
11.3 Ability Pharma
11.3.1 Ability Pharma Company Profile
11.3.2 Oncology Product Overview
11.3.3 Ability Pharma Oncology Market Performance (2018-2023)
11.3.4 Ability Pharma Business Overview
11.4 Acadia Pharmaceuticals Inc.
11.4.1 Acadia Pharmaceuticals Inc. Company Profile
11.4.2 Oncology Product Overview
11.4.3 Acadia Pharmaceuticals Inc. Oncology Market Performance (2018-2023)
11.4.4 Acadia Pharmaceuticals Inc. Business Overview
11.5 Amgen Inc.
11.5.1 Amgen Inc. Company Profile
11.5.2 Oncology Product Overview
11.5.3 Amgen Inc. Oncology Market Performance (2018-2023)
11.5.4 Amgen Inc. Business Overview
11.6 Takeda Oncology
11.6.1 Takeda Oncology Company Profile
11.6.2 Oncology Product Overview
11.6.3 Takeda Oncology Oncology Market Performance (2018-2023)
11.6.4 Takeda Oncology Business Overview
11.7 Aslan Pharmaceuticals Ltd.
11.7.1 Aslan Pharmaceuticals Ltd. Company Profile
11.7.2 Oncology Product Overview
11.7.3 Aslan Pharmaceuticals Ltd. Oncology Market Performance (2018-2023)
11.7.4 Aslan Pharmaceuticals Ltd. Business Overview
11.8 Aspen Pharmacare Holdings Limited.
11.8.1 Aspen Pharmacare Holdings Limited. Company Profile
11.8.2 Oncology Product Overview
11.8.3 Aspen Pharmacare Holdings Limited. Oncology Market Performance (2018-2023)
11.8.4 Aspen Pharmacare Holdings Limited. Business Overview
11.9 Astrazeneca
11.9.1 Astrazeneca Company Profile
11.9.2 Oncology Product Overview
11.9.3 Astrazeneca Oncology Market Performance (2018-2023)
11.9.4 Astrazeneca Business Overview
11.10 Athenex Inc.
11.10.1 Athenex Inc. Company Profile
11.10.2 Oncology Product Overview
11.10.3 Athenex Inc. Oncology Market Performance (2018-2023)
11.10.4 Athenex Inc. Business Overview
12 Research Findings and Conclusion

List of Tables and Figures

Figure Oncology Picture
Table Product Definition of Oncology
Table Global Oncology Market Share by Type (2023 VS 2029)
Table Global Oncology Market Share by Application (2023 VS 2029)
Figure Global Oncology Market Size & Forecast (2018-2029)
Table Oncology Market Size by Regions: 2018 VS 2023 VS 2029
Table Oncology Historic Market Size by Regions (2018-2023)
Table Oncology Historic Market Share by Regions (2018-2023)
Table Oncology Forecasted Market Size by Regions (2023-2029)
Table Oncology Forecasted Market Share by Regions (2023-2029)
Figure North America Oncology Market Size & Forecast (2018-2029)
Figure Europe Oncology Market Size & Forecast (2018-2029)
Figure Asia-Pacific Oncology Market Size & Forecast (2018-2029)
Figure Latin America Oncology Market Size & Forecast (2018-2029)
Figure Middle East & Africa Oncology Market Size & Forecast (2018-2029)
Table North America Oncology Revenue by Countries (2018-2029)
Table North America Oncology Revenue Market Share by Countries (2018-2029)
Table North America Oncology Revenue Share by Players 2022
Table North America Oncology Revenue by Types (2018-2023)
Table North America Oncology Revenue Market Share by Types (2018-2023)
Table North America Oncology Revenue by Applications (2018-2023)
Table North America Oncology Revenue Market Share by Applications (2018-2023)
Figure United States Oncology Revenue and Growth (2018-2029)
Figure Canada Oncology Revenue and Growth (2018-2029)
Table Asia-Pacific Oncology Revenue by Countries (2018-2029)
Table Asia-Pacific Oncology Revenue Market Share by Countries (2018-2029)
Table Asia Pacific Oncology Revenue Share by Players 2022
Table Asia Pacific Oncology Revenue by Types (2018-2023)
Table Asia Pacific Oncology Revenue Market Share by Types (2018-2023)
Table Asia Pacific Oncology Revenue by Applications (2018-2023)
Table Asia Pacific Oncology Revenue Market Share by Applications (2018-2023)
Figure China Oncology Revenue and Growth (2018-2029)
Figure Japan Oncology Revenue and Growth (2018-2029)
Figure Korea Oncology Revenue and Growth (2018-2029)
Figure Southeast Asia Oncology Revenue and Growth (2018-2029)
Figure India Oncology Revenue and Growth (2018-2029)
Figure Australia Oncology Revenue and Growth (2018-2029)
Table Europe Oncology Revenue by Countries (2018-2029)
Table Europe Oncology Revenue Market Share by Countries (2018-2029)
Table Europe Oncology Revenue Share by Players 2022
Table Europe Oncology Revenue by Types (2018-2023)
Table Europe Oncology Revenue Market Share by Types (2018-2023)
Table Europe Oncology Revenue by Applications (2018-2023)
Table Europe Oncology Revenue Market Share by Applications (2018-2023)
Figure Germany Oncology Revenue and Growth (2018-2029)
Figure France Oncology Revenue and Growth (2018-2029)
Figure UK Oncology Revenue and Growth (2018-2029)
Figure Italy Oncology Revenue and Growth (2018-2029)
Figure Russia Oncology Revenue and Growth (2018-2029)
Figure Spain Oncology Revenue and Growth (2018-2029)
Figure Nordic Oncology Revenue and Growth (2018-2029)
Table Latin America Oncology Revenue by Countries (2018-2029)
Table Latin America Oncology Revenue Market Share by Countries (2018-2029)
Table Latin America Oncology Revenue Share by Players 2022
Table Latin America Oncology Revenue by Types (2018-2023)
Table Latin America Oncology Revenue Market Share by Types (2018-2023)
Table Latin America Oncology Revenue by Applications (2018-2023)
Table Latin America Oncology Revenue Market Share by Applications (2018-2023)
Figure Brazil Oncology Revenue and Growth (2018-2029)
Figure Argentina Oncology Revenue and Growth (2018-2029)
Figure Colombia Oncology Revenue and Growth (2018-2029)
Figure Mexico Oncology Revenue and Growth (2018-2029)
Table Middle East & Africa Oncology Revenue by Countries (2018-2029)
Table Middle East & Africa Oncology Revenue Market Share by Countries (2018-2029)
Table Latin America Oncology Revenue Share by Players 2022
Table Middle East & Africa Oncology Revenue by Types (2018-2023)
Table Middle East & Africa Oncology Revenue Market Share by Types (2018-2023)
Table Middle East & Africa Oncology Revenue by Applications (2018-2023)
Table Middle East & Africa Oncology Revenue Market Share by Applications (2018-2023)
Figure Egypt Oncology Revenue and Growth (2018-2029)
Figure South Africa Oncology Revenue and Growth (2018-2029)
Figure Israel Oncology Revenue and Growth (2018-2029)
Figure Turkey Oncology Revenue and Growth (2018-2029)
Figure GCC Countries Oncology Revenue and Growth (2018-2029)
Table Global Oncology Revenue and Market Size by Type (2018-2023)
Table Global Oncology Revenue and Market Share by Type (2018-2023)
Table Global Oncology Market Size Forecast by Type (2023-2029)
Table Global Oncology Market Share Forecast by Type (2023-2029)
Table Global Oncology Revenue Market Size by Application (2018-2023)
Table Global Oncology Revenue Market Share by Application (2018-2023)
Table Global Oncology Revenue Market Size by Application (2023-2029)
Table Global Oncology Revenue Market Share by Application (2023-2029)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Market Mergers & Acquisitions
Table Market New Entrants and Expansion Plans
Table Aegerion Pharmaceuticals Inc. Profile
Table Product Overview
Table Aegerion Pharmaceuticals Inc. Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Aegerion Pharmaceuticals Inc. Revenue and Growth Rate
Figure Aegerion Pharmaceuticals Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Abbvie Inc. Profile
Table Product Overview
Table Abbvie Inc. Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Abbvie Inc. Revenue and Growth Rate
Figure Abbvie Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Ability Pharma Profile
Table Product Overview
Table Ability Pharma Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Ability Pharma Revenue and Growth Rate
Figure Ability Pharma Revenue Market Share 2017-2022
Table Business Overview
Table Acadia Pharmaceuticals Inc. Profile
Table Product Overview
Table Acadia Pharmaceuticals Inc. Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Acadia Pharmaceuticals Inc. Revenue and Growth Rate
Figure Acadia Pharmaceuticals Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Amgen Inc. Profile
Table Product Overview
Table Amgen Inc. Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Amgen Inc. Revenue and Growth Rate
Figure Amgen Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Takeda Oncology Profile
Table Product Overview
Table Takeda Oncology Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Takeda Oncology Revenue and Growth Rate
Figure Takeda Oncology Revenue Market Share 2017-2022
Table Business Overview
Table Aslan Pharmaceuticals Ltd. Profile
Table Product Overview
Table Aslan Pharmaceuticals Ltd. Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Aslan Pharmaceuticals Ltd. Revenue and Growth Rate
Figure Aslan Pharmaceuticals Ltd. Revenue Market Share 2017-2022
Table Business Overview
Table Aspen Pharmacare Holdings Limited. Profile
Table Product Overview
Table Aspen Pharmacare Holdings Limited. Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Aspen Pharmacare Holdings Limited. Revenue and Growth Rate
Figure Aspen Pharmacare Holdings Limited. Revenue Market Share 2017-2022
Table Business Overview
Table Astrazeneca Profile
Table Product Overview
Table Astrazeneca Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Astrazeneca Revenue and Growth Rate
Figure Astrazeneca Revenue Market Share 2017-2022
Table Business Overview
Table Athenex Inc. Profile
Table Product Overview
Table Athenex Inc. Oncology Revenue, Gross and Gross Margin (2017-2022)
Figure Athenex Inc. Revenue and Growth Rate
Figure Athenex Inc. Revenue Market Share 2017-2022
Table Business Overview
Table Research Findings and Conclusion